Results 11 to 20 of about 301,386 (199)

Inflammatory breast cancer: An overview [PDF]

Critical Reviews in Oncology/Hematology, 2015
Inflammatory breast cancer (IBC) is the most aggressive entity of breast cancer. Management involves coordination of multidisciplinary management and usually includes neoadjuvant chemotherapy, ablative surgery if a tumor-free resection margin is expected and locoregional radiotherapy.
Uden, D.J. van, Laarhoven, H.W.M. van, Westenberg, A.H., Wilt, J.H. de, Blanken-Peeters, C.F.   +4 more
openaire   +3 more sources

Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC

BMC Cancer, 2020
Background The purpose of this study was to determine the prognostic role of hormone receptor (HR) on inflammatory breast cancer (IBC) to elucidate its aggressive biological behavior.
Toshiaki Iwase, Kenichi Harano, Hiroko Masuda, Kumiko Kida, Kenneth R. Hess, Ying Wang, Luc Dirix, Steven J. Van Laere, Anthony Lucci, Savitri Krishnamurthy, Wendy A. Woodward, Rachel M. Layman, François Bertucci, Naoto T. Ueno   +13 more
doaj   +1 more source

Inflammatory breast cancer [PDF]

BMJ Case Reports, 2013
A 55-year-old woman presented with a few months’ complaints of weight loss, fatigue, shortness of breath and a rapidly growing right breast mass. She had no family history of breast cancer. Physical examination showed a cachectic patient with a firm, indurated, …
Nikolaos A, Trikalinos, Jean, Yared
openaire   +2 more sources

Pro-inflammatory Cytokine Levels and Cancer-related Fatigue in Breast Cancer Survivors: Effects of an Exercise Adherence Program [PDF]

, 2020
Purpose: This study aimed to determine the effect of an exercise intervention on subjective cancer-related fatigue (CRF) and pro-inflammatory cytokine levels in breast cancer survivors (BCS).
한지희, 이향규, 김수
core   +1 more source

A phase II study of talimogene laherparepvec for patients with inoperable locoregional recurrence of breast cancer

Scientific Reports, 2021
Talimogene laherparepvec (T-VEC) is an immunotherapy that generates local tumor lysis and systemic antitumor immune response. We studied the efficacy of intratumoral administration of T-VEC as monotherapy for inoperable locoregional recurrence of breast ...
Megumi Kai, Angela N. Marx, Diane D. Liu, Yu Shen, Hui Gao, James M. Reuben, Gary Whitman, Savitri Krishnamurthy, Merrick I. Ross, Jennifer K. Litton, Bora Lim, Nuhad Ibrahim, Takahiro Kogawa, Naoto T. Ueno   +13 more
doaj   +1 more source

Identification of barriers at the primary care provider level to improve inflammatory breast cancer diagnosis and management

Preventive Medicine Reports, 2023
The purpose of this study, based in the United States, was to evaluate knowledge gaps and barriers related to diagnosis and care of inflammatory breast cancer (IBC), a rare but lethal breast cancer subtype, amongst Primary Care Providers (PCP) as they ...
Gayathri R. Devi, Laura J. Fish, Alexandra Bennion, Gregory E. Sawin, Sarah M. Weaver, Katherine Reddy, Rashmi Saincher, Anh N. Tran   +7 more
doaj   +1 more source

Lipocalin 2 promotes inflammatory breast cancer tumorigenesis and skin invasion

Molecular Oncology, 2021
Inflammatory breast cancer (IBC) is an aggressive form of primary breast cancer characterized by rapid onset and high risk of metastasis and poor clinical outcomes.
Emilly S. Villodre, Xiaoding Hu, Richard Larson, Pascal Finetti, Kristen Gomez, Wintana Balema, Shane R. Stecklein, Ginette Santiago‐Sanchez, Savitri Krishnamurthy, Juhee Song, Xiaoping Su, Naoto T. Ueno, Debu Tripathy, Steven Van Laere, François Bertucci, Pablo Vivas‐Mejía, Wendy A. Woodward, Bisrat G. Debeb   +17 more
doaj   +1 more source

Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers

Genome Medicine, 2021
Background Inflammatory breast cancer (IBC) has a highly invasive and metastatic phenotype. However, little is known about its genetic drivers. To address this, we report the largest cohort of whole-genome sequencing (WGS) of IBC cases.
Xiaotong Li, Sushant Kumar, Arif Harmanci, Shantao Li, Robert R. Kitchen, Yan Zhang, Vikram B. Wali, Sangeetha M. Reddy, Wendy A. Woodward, James M. Reuben, Joel Rozowsky, Christos Hatzis, Naoto T. Ueno, Savitri Krishnamurthy, Lajos Pusztai, Mark Gerstein   +15 more
doaj   +1 more source

The potential effects and mechanisms of breast inflammatory lesions on the occurrence and development of breast cancer

Frontiers in Oncology, 2022
Breast cancer as the most common cancer in women has become the leading cause of cancer death for women. Although many inflammatory factors increase the risk of breast cancer, there are very few studies on the mechanisms by which inflammation affects the
Zhaoxia Chang, Ying Zhang, Ying Zhang, Jue Fan, Lixing Zhang, Suling Liu, Guangyu Liu, Guangyu Liu, Juchuanli Tu   +8 more
doaj   +1 more source

Dermoscopy of inflammatory breast cancer [PDF]

Anais Brasileiros de Dermatologia, 2018
Inflammatory breast cancer is an aggressive and infiltrative malignancy that is often misdiagnosed as an infection because of its symptoms and signs of inflammation, delaying proper diagnosis and treatment. We report a case of inflammatory breast cancer showing correlation between dermoscopic and histopathological diagnoses. We highlight the utility of
María Gabriela Vallone, Virginia Mariana González, José Gabriel Casas, Margarita Larralde   +3 more
openaire   +3 more sources